681 related articles for article (PubMed ID: 33750405)
1. High concentrations of illicit stimulants and cutting agents cause false positives on fentanyl test strips.
Lockwood TE; Vervoordt A; Lieberman M
Harm Reduct J; 2021 Mar; 18(1):30. PubMed ID: 33750405
[TBL] [Abstract][Full Text] [Related]
2. Fentanyl test strips as an opioid overdose prevention strategy: Findings from a syringe services program in the Southeastern United States.
Peiper NC; Clarke SD; Vincent LB; Ciccarone D; Kral AH; Zibbell JE
Int J Drug Policy; 2019 Jan; 63():122-128. PubMed ID: 30292493
[TBL] [Abstract][Full Text] [Related]
3. Testing the test strips: laboratory performance of fentanyl test strips.
Halifax JC; Lim L; Ciccarone D; Lynch KL
Harm Reduct J; 2024 Jan; 21(1):14. PubMed ID: 38238757
[TBL] [Abstract][Full Text] [Related]
4. Evaluating the sensitivity, stability, and cross-reactivity of commercial fentanyl immunoassay test strips.
Rodriguez-Cruz SE
J Forensic Sci; 2023 Sep; 68(5):1555-1569. PubMed ID: 37420315
[TBL] [Abstract][Full Text] [Related]
5. Assessment of two brands of fentanyl test strips with 251 synthetic opioids reveals "blind spots" in detection capabilities.
Hayes KL; Lieberman M
Harm Reduct J; 2023 Dec; 20(1):175. PubMed ID: 38057832
[TBL] [Abstract][Full Text] [Related]
6. Validation of a lateral flow chromatographic immunoassay for the detection of fentanyl in drug samples.
Park JN; Sherman SG; Sigmund V; Breaud A; Martin K; Clarke WA
Drug Alcohol Depend; 2022 Nov; 240():109610. PubMed ID: 36115223
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a fentanyl drug checking service for clients of a supervised injection facility, Vancouver, Canada.
Karamouzian M; Dohoo C; Forsting S; McNeil R; Kerr T; Lysyshyn M
Harm Reduct J; 2018 Sep; 15(1):46. PubMed ID: 30200991
[TBL] [Abstract][Full Text] [Related]
8. Drug checking as a potential strategic overdose response in the fentanyl era.
Laing MK; Tupper KW; Fairbairn N
Int J Drug Policy; 2018 Dec; 62():59-66. PubMed ID: 30359874
[TBL] [Abstract][Full Text] [Related]
9. Current attitudes toward drug checking services and a comparison of expected with actual drugs present in street drug samples collected from opioid users.
Swartz JA; Lieberman M; Jimenez AD; Mackesy-Amiti ME; Whitehead HD; Hayes KL; Taylor L; Prete E
Harm Reduct J; 2023 Jul; 20(1):87. PubMed ID: 37420196
[TBL] [Abstract][Full Text] [Related]
10. Selectivity and sensitivity of urine fentanyl test strips to detect fentanyl analogues in illicit drugs.
Bergh MS; Øiestad ÅML; Baumann MH; Bogen IL
Int J Drug Policy; 2021 Apr; 90():103065. PubMed ID: 33333419
[TBL] [Abstract][Full Text] [Related]
11. Consumer discernment of fentanyl in illicit opioids confirmed by fentanyl test strips: Lessons from a syringe services program in North Carolina.
Zibbell JE; Peiper NC; Duhart Clarke SE; Salazar ZR; Vincent LB; Kral AH; Feinberg J
Int J Drug Policy; 2021 Jul; 93():103128. PubMed ID: 33487527
[TBL] [Abstract][Full Text] [Related]
12. Use of rapid fentanyl test strips among young adults who use drugs.
Krieger MS; Goedel WC; Buxton JA; Lysyshyn M; Bernstein E; Sherman SG; Rich JD; Hadland SE; Green TC; Marshall BDL
Int J Drug Policy; 2018 Nov; 61():52-58. PubMed ID: 30344005
[TBL] [Abstract][Full Text] [Related]
13. Fentanyl and heroin contained in seized illicit drugs and overdose-related deaths in British Columbia, Canada: An observational analysis.
Baldwin N; Gray R; Goel A; Wood E; Buxton JA; Rieb LM
Drug Alcohol Depend; 2018 Apr; 185():322-327. PubMed ID: 29486421
[TBL] [Abstract][Full Text] [Related]
14. The rising crisis of illicit fentanyl use, overdose, and potential therapeutic strategies.
Han Y; Yan W; Zheng Y; Khan MZ; Yuan K; Lu L
Transl Psychiatry; 2019 Nov; 9(1):282. PubMed ID: 31712552
[TBL] [Abstract][Full Text] [Related]
15. Monitoring for fentanyl within Australian supervised injecting facilities: Findings from feasibility testing of novel methods and collaborative workshops.
Nielsen S; Barratt M; Hiley S; Bartlett M; Latimer J; Jauncey M; Roux C; Morelato M; Clark N; Kowalski M; Gilbert M; Francia L; Shipton A; Gerostamoulos D; Glowacki L; Lam T
Int J Drug Policy; 2023 May; 115():104015. PubMed ID: 37043848
[TBL] [Abstract][Full Text] [Related]
16. "If I had them, I would use them every time": Perspectives on fentanyl test strip use from people who use drugs.
Reed MK; Salcedo VJ; Guth A; Rising KL
J Subst Abuse Treat; 2022 Sep; 140():108790. PubMed ID: 35577663
[TBL] [Abstract][Full Text] [Related]
17. Initial results of a drug checking pilot program to detect fentanyl adulteration in a Canadian setting.
Tupper KW; McCrae K; Garber I; Lysyshyn M; Wood E
Drug Alcohol Depend; 2018 Sep; 190():242-245. PubMed ID: 30064061
[TBL] [Abstract][Full Text] [Related]
18. Exposure to fentanyl-contaminated heroin and overdose risk among illicit opioid users in Rhode Island: A mixed methods study.
Carroll JJ; Marshall BDL; Rich JD; Green TC
Int J Drug Policy; 2017 Aug; 46():136-145. PubMed ID: 28578864
[TBL] [Abstract][Full Text] [Related]
19. Fentanyl-associated fatalities among illicit drug users in Wayne County, Michigan (July 2005-May 2006).
Algren DA; Monteilh CP; Punja M; Schier JG; Belson M; Hepler BR; Schmidt CJ; Miller CE; Patel M; Paulozzi LJ; Straetemans M; Rubin C
J Med Toxicol; 2013 Mar; 9(1):106-15. PubMed ID: 23359211
[TBL] [Abstract][Full Text] [Related]
20. An assessment of the limits of detection, sensitivity and specificity of three devices for public health-based drug checking of fentanyl in street-acquired samples.
Green TC; Park JN; Gilbert M; McKenzie M; Struth E; Lucas R; Clarke W; Sherman SG
Int J Drug Policy; 2020 Mar; 77():102661. PubMed ID: 31951925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
